Skip to content

Chemed CHE Income Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$2.54B+0.4%$2.53B0.0%$2.53B+0.7%$2.51B+0.9%$2.49B+2.4%
$1.72B+0.7%$1.71B+0.5%$1.7B+1.9%$1.67B+2.7%$1.62B+2.9%
$822.54M-0.1%$823.18M-1.1%$832.13M-1.5%$845.22M-2.5%$866.66M+1.4%
32.4%-0.2pp32.5%-0.3pp32.9%-0.8pp33.6%-1.2pp34.8%-0.3pp
$425.92M+2.1%$417.19M+0.3%$415.94M+0.9%$412.14M-0.5%$414.07M-2.4%
$2.21B+0.9%$2.19B+0.6%$2.18B+1.7%$2.14B+2.0%$2.1B+1.7%
$2.21B+0.9%$2.19B+0.6%$2.18B+1.7%$2.14B+2.0%$2.1B+1.7%
$328.07M-3.0%$338.25M-3.8%$351.47M-4.7%$368.88M-5.2%$388.92M+6.1%
12.9%-0.5pp13.4%-0.5pp13.9%-0.8pp14.7%-0.9pp15.6%+0.6pp
$1.93M+10.5%$1.75M+1.3%$1.73M+1.8%$1.7M+0.8%$1.68M-5.4%
$22.81M+18.3%$19.28M-6.9%$20.71M-0.2%$20.76M-11.3%$23.42M-32.6%
59,927,700,000%-683,400,000%60,611,100,000%-4,368,700,000%64,979,800,000%-1,748,500,000%66,728,300,000%-2,271,300,000%68,999,600,000%+1,118,900,000%
$89.16M-1.5%$90.54M-1.2%$91.65M-6.1%$97.6M-4.2%$101.92M+4.6%
$259.78M-2.1%$265.24M-4.9%$278.81M-4.0%$290.35M-6.0%$308.74M+2.2%
10.2%-0.3pp10.5%-0.5pp11%-0.5pp11.6%-0.8pp12.4%0.0pp
$18.32-0.1%$18.34-3.0%$18.90-2.8%$19.44-5.3%$20.52+3.1%
$393.76M-2.3%$403.09M-3.1%$415.81M-3.9%$432.68M-4.3%$452.18M+5.3%
15.5%-0.4pp15.9%-0.5pp16.4%-0.8pp17.2%-0.9pp18.2%+0.5pp
$328.07M-3.0%$338.25M-3.8%$351.47M-4.7%$368.88M-5.2%$388.92M+6.1%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Chemed's revenue?
Chemed (CHE) generated $2.5B in revenue over the trailing twelve months, up 2.1% year over year.
Is Chemed profitable?
Chemed reported $259.8M in net income over the trailing twelve months, a 10.2% net margin.
What are Chemed's profit margins?
Gross margin is 32.4% and operating margin is 12.9%, with a 10.2% net margin.
What is Chemed's earnings per share?
Chemed's diluted EPS over the trailing twelve months is $18.32.
Where does Chemed's income statement data come from?
Every line is extracted from Chemed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.